Skip to main content
. 2019 May 8;11(5):826–836. doi: 10.1080/19420862.2019.1608143

Figure 1.

Figure 1.

Major glycan structures of therapeutic mAbs. (a) Core-fucosylated agalacto-biantennary complex-type glycan (G0F); (b) core-fucosylated biantennary complex-type glycan with galactosylation on the Man α1-6 arm (G1aF); (c) core-fucosylated biantennary complex-type glycan with galactosylation on the Man α1-3 arm (G1bF); (d) core-fucosylated and fully galactosylated biantennary complex-type glycan (G2F). Yellow circle, Gal; green circle, Man; blue square, N-acetylglucosamine; red triangle, fucose.